The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Biology of Gastrointestinal Stromal Tumors
Abstract
Once a poorly defined pathologic oddity, in recent years, gastrointestinal stromal tumor (GIST) has emerged as a distinct oncogenetic entity that is now center stage in clinical trials of kinase-targeted therapies. This review charts the rapid progress that has established GIST as a model for understanding the role of oncogenic kinase mutations in human tumorigenesis. Approximately 80% to 85% of GISTs harbor activating mutations of the KIT tyrosine kinase. In a series of 322 GISTs (including 140 previously published cases) studied by the authors in detail, mutations in the KIT gene occurred with decreasing frequency in exons 11 (66.1%), 9 (13%), 13 (1.2%), and 17 (0.6%). In the same series, a subset of tumors had mutations in the KIT-related kinase gene PDGF receptor alpha (PDGFRA), which occurred in either exon 18 (5.6%) or 12 (1.5%). The remainder of GISTs (12%) were wild type for both KIT and PDGFRA. Comparative studies of KIT-mutant, PDGFRA-mutant, and wild-type GISTs indicate that there are many similarities between these groups of tumors but also important differences. In particular, the responsiveness of GISTs to treatment with the kinase inhibitor imatinib varies substantially depending on the exonic location of the KIT or PDGFRA mutation. Given these differences, which have implications both for the diagnosis and treatment of GISTs, we propose a molecular-based classification of GIST. Recent studies of familial GIST, pediatric GIST, and variant forms of GIST related to Carney's triad and neurofibromatosis type 1 are discussed in relationship to this molecular classification. In addition, the role of mutation screening in KIT and PDGFRA as a diagnostic and prognostic aid is emphasized in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,490
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
Demetri, G. D., von Mehren, M., Blanke, C. D., Van den Abbeele, A. D., Eisenberg, B., Roberts, P. J., Heinrich, M. C., Tuveson, D. A., Singer, S., Janicek, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020461 · Cited by 4,389
Self-citationDiagnosis of gastrointestinal stromal tumors: A consensus approach
Fletcher, C. D. M., Berman, J. J., Corless, C., Gorstein, F., Lasota, J., Longley, B. J., Miettinen, M., O'Leary, T. J., Remotti, H., Rubin, B. P., et al. (2002) · Human Pathology · doi:10.1053/hupa.2002.123545 · Cited by 3,419
Self-citationClinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N., & Sawyers, C. L. (2001) · Science · doi:10.1126/science.1062538 · Cited by 3,104
Two Hundred Gastrointestinal Stromal Tumors: Recurrence Patterns and Prognostic Factors for Survival
DeMatteo, R. P., Lewis, J. J., Leung, D., Mudan, S. S., Woodruff, J. M., & Brennan, M. F. (2000) · Annals of Surgery · doi:10.1097/00000658-200001000-00008 · Cited by 2,554
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
Heinrich, M. C., Corless, C. L., Duensing, A., McGreevey, L., Chen, C.-J., Joseph, N., Singer, S., Griffith, D. J., Haley, A., Town, A., et al. (2003) · Science · doi:10.1126/science.1079666 · Cited by 2,301
Self-citationKinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
Heinrich, M. C., Corless, C. L., Demetri, G. D., Blanke, C. D., von Mehren, M., Joensuu, H., McGreevey, L. S., Chen, C.-J., Van den Abbeele, A. D., Druker, B. J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.190 · Cited by 2,299
Self-citationJoensuu, H., Roberts, P. J., Sarlomo-Rikala, M., Andersson, L. C., Tervahartiala, P., Tuveson, D., Silberman, S. L., Capdeville, R., Dimitrijevic, S., Druker, B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441404 · Cited by 2,037
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C., Niederwieser, D., Resta, D., Capdeville, R., Zoellner, U., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011573 · Cited by 2,019
Miettinen, M., & Lasota, J. (2001) · Virchows Archiv · doi:10.1007/s004280000338 · Cited by 1,854
Kindblom, L. G., Remotti, H. E., Aldenborg, F., & Meis‐Kindblom, J. M. (1998) · Europe PMC (PubMed Central) · Cited by 1,667
Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.
Yarden, Y., Kuang, W. J., Yang-Feng, T., Coussens, L., Munemitsu, S., Dull, T. J., Chen, E., Schlessinger, J., Francke, U., & Ullrich, A. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02655.x · Cited by 1,574
W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity
Hulzinga, J. D., Thuneberg, L., Klüppel, M., Malysz, J., Mikkelsen, H. B., & Bernstein, A. (1995) · Nature · doi:10.1038/373347a0 · Cited by 1,400
Buchdunger, E., Cioffi, C. L., Law, N., Stover, D., Ohno-Jones, S., Druker, B. J., & Lydon, N. B. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38879-2 · Cited by 1,274
van Oosterom, A. T., Judson, I., Verweij, J., Stroobants, S., di Paola, E. D., Dimitrijevic, S., Martens, M., Webb, A., Sciot, R., Van Glabbeke, M., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06535-7 · Cited by 1,264
Heinrich, M. C., Griffith, D. J., Druker, B. J., Wait, C. L., Ott, K. A., & Zigler, A. J. (2000) · Blood · doi:10.1182/blood.v96.3.925 · Cited by 1,071
Self-citationKIT activation is a ubiquitous feature of gastrointestinal stromal tumors.
Rubin, B. P., Singer, S., Tsao, C., Duensing, A. U., Lux, M. L., Ruiz, R., Hibbard, M. K., Chen, C. J., Xiao, S., Tuveson, D. A., et al. (2001) · PubMed · Cited by 959
Self-citationFuritsu, T., Tsujimura, T., Tono, T., Ikeda, H., Kitayama, H., Koshimizu, U., Sugahara, H., Butterfield, J. H., Ashman, L. K., & Kanayama, Y. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116761 · Cited by 816
Miettinen, M., Furlong, M., Sarlomo-Rikala, M., Burke, A., Sobin, L. H., & Lasota, J. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200109000-00002 · Cited by 731
Tuveson, D. A., Willis, N. A., Jacks, T., Griffin, J. D., Singer, S., Fletcher, C. D., Fletcher, J. A., & Demetri, G. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204704 · Cited by 695
Self-citationHirota, S., Ohashi, A., Nishida, T., Isozaki, K., Kinoshita, K., Shinomura, Y., & Kitamura, Y. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01046-1 · Cited by 666
Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: A review
Miettinen, M., El-Rifai, W., H, L., & Lasota, J. (2002) · Human Pathology · doi:10.1053/hupa.2002.124123 · Cited by 663
Branford, S., Rudzki, Z., Walsh, S., Grigg, A., Arthur, C., Taylor, K., Herrmann, R., Lynch, K. P., & Hughes, T. P. (2002) · Blood · doi:10.1182/blood.v99.9.3472 · Cited by 649
KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal Tumors
Lux, M. L., Rubin, B. P., Biase, T. L., Chen, C.-J., Maclure, T., Demetri, G., Xiao, S., Singer, S., Fletcher, C. D. M., & Fletcher, J. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64946-2 · Cited by 642
Self-citationClinical management of gastrointestinal stromal tumors: Before and after STI-571
Dematteo, R. P., Heinrich, M. C., El-Rifai, W. M., & Demetri, G. (2002) · Human Pathology · doi:10.1053/hupa.2002.124122 · Cited by 637
Self-citationBesmer, P., Murphy, J. E., George, P. C., Qiu, F., Bergold, P. J., Lederman, L., Snyder, H. W., Brodeur, D., Zuckerman, E. E., & Hardy, W. D. (1986) · Nature · doi:10.1038/320415a0 · Cited by 629
Miettinen, M., Sobin, L. H., & Sarlomo-Rikala, M. (2000) · Modern Pathology · doi:10.1038/modpathol.3880210 · Cited by 626
Prognosis of Gastrointestinal Smooth-Muscle (Stromal) Tumors: Dependence on Anatomic Site
Emory, T. S., Sobin, L. H., Lukes, L., Lee, D. H., & O'Leary, T. J. (1999) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199901000-00009 · Cited by 625
Longley, B. J., Tyrrell, L., Lu, S.-Z., Ma, Y.-S., Langley, K., Ding, T.-G., Duffy, T., Jacobs, P., Tang, L. H., & Modlin, I. (1996) · Nature Genetics · doi:10.1038/ng0396-312 · Cited by 607
Familial gastrointestinal stromal tumours with germline mutation of the KIT gene
Nishida, T., Hirota, S., Taniguchi, M., Hashimoto, K., Isozaki, K., Nakamura, H., Kanakura, Y., Tanaka, T., Takabayashi, A., Matsuda, H., et al. (1998) · Nature Genetics · doi:10.1038/1209 · Cited by 586
Molecular characterisation of soft tissue tumours: a gene expression study
Nielsen, T. O., West, R. B., Linn, S. C., Alter, O., Knowling, M. A., O'Connell, J. X., Zhu, S., Fero, M., Sherlock, G., Pollack, J. R., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08270-3 · Cited by 576
The biology of stem cell factor and its receptor C-kit
Ashman, L. K. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00076-x · Cited by 576
Management of malignant gastrointestinal stromal tumours
Joensuu, H., Fletcher, C., Dimitrijevic, S., Silberman, S., Roberts, P., & Demetri, G. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00899-9 · Cited by 567
Longley, B. J., Metcalfe, D. D., Tharp, M., Wang, X., Tyrrell, L., Lu, S.-Z., Heitjan, D., & Ma, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1609 · Cited by 552
Roche-Lestienne, C., Soenen-Cornu, V., Grardel-Duflos, N., Laı̈, J.-L., Philippe, N., Facon, T., Fenaux, P., & Preudhomme, C. (2002) · Blood · doi:10.1182/blood.v100.3.1014 · Cited by 515
Nocka, K., Majumder, S., Chabot, B., Ray, P., Cervone, M., Bernstein, A., & Besmer, P. (1989) · Genes & Development · doi:10.1101/gad.3.6.816 · Cited by 474
Heinrich, M. C., Rubin, B. P., Longley, B. J., & Fletcher, J. A. (2002) · Human Pathology · doi:10.1053/hupa.2002.124124 · Cited by 455
Self-citationCorless, C. L., McGreevey, L., Haley, A., Town, A., & Heinrich, M. C. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61103-0 · Cited by 444
Self-citationEffect of c-kit Mutation on Prognosis of Gastrointestinal Stromal Tumors
谷口, 正. (2001) · Cited by 438
Carney, J. A. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.6.543 · Cited by 435
Singer, S., Rubin, B. P., Lux, M. L., Chen, C.-J., Demetri, G. D., Fletcher, C. D. �., & Fletcher, J. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.03.095 · Cited by 420
Self-citationActivating c-kit Gene Mutations in Human Germ Cell Tumors
Tian, Q., Frierson, H. F., Krystal, G. W., & Moskaluk, C. A. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65419-3 · Cited by 408
Zöller, M. E. T., Rembeck, B., Odén, A., Samuelsson, M., & Angervall, L. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970601)79:11<2125::aid-cncr9>3.3.co;2-b · Cited by 395
Miettinen, M., Kopczynski, J., Makhlouf, H. R., Sarlomo-Rikala, M., Gyorffy, H., Burke, A., Sobin, L. H., & Lasota, J. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200305000-00006 · Cited by 391
Early signaling pathways activated by c-Kit in hematopoietic cells
Linnekin, D. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00078-3 · Cited by 385
Antonescu, C. R., Sommer, G., Sarran, L., Tschernyavsky, S. J., Riedel, E., Woodruff, J. M., Robson, M. E., Maki, R. G., Brennan, M. F., Ladanyi, M., et al. (2003) · PubMed · Cited by 359
Familial paraganglioma and gastric stromal sarcoma: A new syndrome distinct from the Carney triad
Carney, J. A., & Stratakis, C. A. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10235 · Cited by 350
Blume-Jensen, P., Claesson-Welsh, L., Siegbahn, A., Zsebo, K. M., Westermark, B., & Heldin, C. H. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04989.x · Cited by 330
Immunohistochemical Staining for KIT (CD117) in Soft Tissue Sarcomas Is Very Limited in Distribution
Hornick, J. L., & Fletcher, C. D. M. (2002) · American Journal of Clinical Pathology · doi:10.1309/lx9u-f7p0-uwdh-8y6r · Cited by 306
c‐kit proto‐oncogene exon 8 in‐frame deletion plus insertion mutations in acute myeloid leukaemia
Gari, M., Goodeve, A., Wilson, G., Winship, P., Langabeer, S., Linch, D., Vandenberghe, E., Peake, I., & Reilly, J. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01449.x · Cited by 262
Shen, Y., Devgan, G., Darnell, J. E., & Bromberg, J. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1543 · Cited by 249
El-Rifai, W. M., Sarlomo‐Rikala, M., Andersson, L. C., Knuutila, S., & Miettinen, M. (2000) · PubMed · Cited by 245
Sommer, G., Agosti, V., Ehlers, I., Rossi, F., Corbacioglu, S., Farkas, J., Moore, M., Manova, K., Antonescu, C. R., & Besmer, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1037763100 · Cited by 244
Klüppel, M., Huizinga, J. D., Malysz, J., & Bernstein, A. (1998) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(199801)211:1<60::aid-aja6>3.0.co;2-5 · Cited by 236
Kitayama, H., Kanakura, Y., Furitsu, T., Tsujimura, T., Oritani, K., Ikeda, H., Sugahara, H., Mitsui, H., Kanayama, Y., & Kitamura, Y. (1995) · Blood · doi:10.1182/blood.v85.3.790.bloodjournal853790 · Cited by 233
Maeyama, H., Hidaka, E., Ota, H., Minami, S., Kajiyama, M., Kuraishi, A., Mori, H., Matsuda, Y., Wada, S., Sodeyama, H., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.20880 · Cited by 231
Wardelmann, E., Losen, I., Hans, V., Neidt, I., Speidel, N., Bierhoff, E., Heinicke, T., Pietsch, T., Büttner, R., & Merkelbach‐Bruse, S. (2003) · International Journal of Cancer · doi:10.1002/ijc.11323 · Cited by 223
Isozaki, K., Terris, B., Belghiti, J., Schiffmann, S., Hirota, S., & Vanderwinden, J.-M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64795-5 · Cited by 223
Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours
Hirota, S., Nishida, T., Isozaki, K., Taniguchi, M., Nakamura, J., Okazaki, T., & Kitamura, Y. (2001) · The Journal of Pathology · Cited by 221
Kozlowski, M., Larose, L., Lee, F., Le, D. M., Rottapel, R., & Siminovitch, K. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.2089 · Cited by 204
Hirota, S., Nishida, T., Isozaki, K., Taniguchi, M., Nishikawa, K., Ohashi, A., Takabayashi, A., Obayashi, T., Okuno, T., Kinoshita, K., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.33024 · Cited by 194
Allander, S. V., Nupponen, N. N., Ringnér, M., Hostetter, G. H., Maher, G. W., Goldberger, N. E., Chen, Y., Carpten, J. D., Elkahloun, A. G., & Meltzer, P. S. (2001) · PubMed · Cited by 182
Tsujimura, T., Furitsu, T., Morimoto, M., Isozaki, K., Nomura, S., Matsuzawa, Y., Kitamura, Y., & Kanakura, Y. (1994) · Blood · doi:10.1182/blood.v83.9.2619.2619 · Cited by 163
Ma, Y., Jack Longley, B., Wang, X., Blount, J. L., Langley, K., & Caughey, G. H. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00488.x · Cited by 161
Autoinhibition of the Kit Receptor Tyrosine Kinase by the Cytosolic Juxtamembrane Region
Chan, P. M., Ilangumaran, S., La Rose, J., Chakrabartty, A., & Rottapel, R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.9.3067-3078.2003 · Cited by 161
c-kit protein, a transmembrane kinase: identification in tissues and characterization.
Majumder, S., Brown, K., Qiu, F. H., & Besmer, P. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.11.4896 · Cited by 160
Piao, X., Paulson, R., van der Geer, P., Pawson, T., & Bernstein, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14665 · Cited by 160
Paulson, R. F., Vesely, S., Siminovitch, K. A., & Bernstein, A. (1996) · Nature Genetics · doi:10.1038/ng0796-309 · Cited by 159
Hirota, S., Okazaki, T., Kitamura, Y., O'Brien, P. K., Kapusta, L. R., & Dardick, I. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200002000-00045 · Cited by 155
Chian, R., Young, S. M., Danilkovitch‐Miagkova, A., Rönnstrand, L., Leonard, E. J., Ferrao, P., Ashman, L. K., & Linnekin, D. (2001) · Blood · doi:10.1182/blood.v98.5.1365 · Cited by 149
High Prognostic Value of p16INK4 Alterations in Gastrointestinal Stromal Tumors
Schneider‐Stock, R., Boltze, C., Lasota, J. P., Miettinen, M., Peters, B., Pross, M., Roessner, A., & Günther, T. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.101 · Cited by 147
Rudolph, P., Gloeckner‐Hofmann, K., Parwaresch, R. M., Harms, D., & Schmidt, D. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90447-6 · Cited by 145
Clary, B. M., DeMatteo, R. P., Lewis, J. J., Leung, D. H. Y., & Brennan, M. F. (2001) · Annals of Surgical Oncology · doi:10.1007/s10434-001-0290-3 · Cited by 139
Zhang, Z., Zhang, R., Joachimiak, A., Schlessinger, J., & Kong, X. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.7732 · Cited by 137
Ma, Y., Cunningham, M. E., Wang, X., Ghosh, I., Regan, L., & Longley, B. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13399 · Cited by 129
Stat1 associates with c-kit and is activated in response to stem cell factor
DeBerry, C. S., Mou, S. M., & Linnekin, D. (1997) · Biochemical Journal · doi:10.1042/bj3270073 · Cited by 127
Stromal Tumors of the Jejunum and Ileum
Brainard, J., & Goldblum, J. R. (1997) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199704000-00006 · Cited by 127
STI571: A Paradigm of New Agents for Cancer Therapeutics
Mauro, M. J., O'Dwyer, M. E., Heinrich, M. C., & Druker, B. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.1.325 · Cited by 127
Self-citationZuzak, T. J., Steinhoff, D., Sutton, L. N., Phillips∥, P. C., Eggert, A., & Grotzer, M. A. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00355-0 · Cited by 117
c‐kit point mutation of extracellular domain in patients with myeloproliferative disorders
Nakata, Y., Kimura, A., Katoh, O., Kawaishi, K., Hyodo, H., Abe, K., Kuramoto, A., & Satow, Y. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05364.x · Cited by 104
Tsujimura, T., Morimoto, M., Hashimoto, K., Moriyama, Y., Kitayama, H., Matsuzawa, Y., Kitamura, Y., & Kanakura, Y. (1996) · Blood · doi:10.1182/blood.v87.1.273.273 · Cited by 102
c‐kit Gene mutation at exon 17 or 13 is very rare in sporadic gastrointestinal stromal tumors
Kinoshita, K., Isozaki, K., Hirota, S., Nishida, T., CHEN, H., Nakahara, M., NAGASAWA, Y., Ohashi, A., Shinomura, Y., Kitamura, Y., et al. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.02911.x · Cited by 89
Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT
Bauer, S., Corless, C. L., Heinrich, M. C., Dirsch, O., Antoch, G., Kanja, J., Seeber, S., & Schütte, J. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0564-x · Cited by 71
Self-citationRequirement of Phosphatidylinositol-3 Kinase for Activation of JNK/SAPKs by PDGF
Lopez-Ilasaca, M. A., Li, W., Üren, A., Yu, J., Kazlauskas, A., Gutkind, J. S., & Heidaran, M. A. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6289 · Cited by 68
Molecular evolution of the genes encoding receptor tyrosine kinase with immunoglobulinlike domains
Rousset, D., Agn�s, F., Lachaume, P., Andr�, C., & Galibert, F. (1995) · Journal of Molecular Evolution · doi:10.1007/bf00160313 · Cited by 63
Targeting the molecular pathophysiology of gastrointestinal stromal tumors with imatinib
Demetri, G. D. (2002) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(02)00052-7 · Cited by 62
Miettinen, M., Sarlomo‐Rikala, M., & Kovatich, A. J. (1998) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050244 · Cited by 50
c-Kit Point mutation in patients with myeloproliferative disorders
Kimura, A., Nakata, Y., Katoh, O., & Hyodo, H. (1997) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199709114167 · Cited by 46
Nakarna, A., Hirota, S., Okazaki, T., Nagano, K., Kawano, S., Hori, M., & Kitamura, Y. (1998) · Pathology International · doi:10.1111/j.1440-1827.1998.tb03850.x · Cited by 27
(2001) · doi:10.1002/1097-0142(20010801)92:3<657::aid-cncr1367>3.0.co;2-d
Cited by
Miettinen, M., & Lasota, J. (2006) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2006-130-1466-gstrom · Cited by 1,459
Ardito, F., Giuliani, M., Perrone, D., Troiano, G., & Muzio, L. L. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3036 · Cited by 1,336
Gastrointestinal stromal tumour
Rubin, B. P., Heinrich, M. C., & Corless, C. L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60780-6 · Cited by 1,036
Self-citationDebiec-Rychter, M., Sciot, R., Le Cesne, A., Schlemmer, M., Hohenberger, P., van Oosterom, A. T., Blay, J.-Y., Leyvraz, S., Stul, M., Casali, P. G., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.030 · Cited by 892
Corless, C. L., Schroeder, A., Griffith, D., Town, A., McGreevey, L., Harrell, P., Shiraga, S., Bainbridge, T., Morich, J., & Heinrich, M. C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.068 · Cited by 849
Self-citation
Metadata
- Authors
- Corless, C. L., Fletcher, J. A., & Heinrich, M. C.
- Venue
- Journal of Clinical Oncology
- Published
- 2004-09-15
- Volume
- 22
- Issue
- 18
- Pages
- 3813-3825
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2101214437
- Cited by
- 1,224
- References
- 90
- FWCI
- 64.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.